Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 2

Expert review on coronary calcium

Authors Matthew J Budoff, Khawar M Gul

Published 11 April 2008 Volume 2008:4(2) Pages 315—324

DOI http://dx.doi.org/10.2147/VHRM.S1160

Matthew J Budoff, Khawar M Gul

Division of Cardiology, Saint John’s Cardiovascular Research Center, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, California, USA

Abstract: While there is no doubt that high risk patients (those with >20% ten year risk of future cardiovascular event) need more aggressive preventive therapy, a majority of cardiovascular events occur in individuals at intermediate risk (10%–20% ten year risk). Accurate risk assessment may be helpful in decreasing cardiovascular events through more appropriate targeting of preventive measures. It has been suggested that traditional risk assessment may be refined with the selective use of coronary artery calcium (CAC) or other methods of subclinical atherosclerosis measurement. Coronary calcification is a marker of atherosclerosis that can be quantified with the use of cardiac CT and it is proportional to the extent and severity of atherosclerotic disease. The published studies demonstrate a high sensitivity of CAC for the presence of coronary artery disease but a lower specificity for obstructive CAD depending on the magnitude of the CAC. Several large clinical trials found clear, incremental predictive value of CAC over the Framingham risk score when used in asymptomatic patients. Based on multiple observational studies, patients with increased plaque burdens (increased CAC) are approximately ten times more likely to suffer a cardiac event over the next 3–5 years. Coronary calcium scores have outperformed conventional risk factors, highly sensitive C-reactive protein (CRP) and carotid intima media thickness (IMT) as a predictor of cardiovascular events. The relevant prognostic information obtained may be useful to initiate or intensify appropriate treatment strategies to slow the progression of atherosclerotic vascular disease. Current data suggests intermediate risk patients may benefit most from further risk stratification with cardiac CT, as CAC testing is effective at identifying increased risk and in motivating effective behavioral changes. This article reviews information pertaining to the clinical use of CAC for assessing coronary atherosclerosis as a useful predictor of coronary artery disease (CAD) in certain population of patients.

Keywords: computed tomography, electron beam, prognosis, review, coronary artery calcification, calcium score, atherosclerosis, multi-detector computed tomography

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Mild and moderate pre-dialysis chronic kidney disease is associated with increased coronary artery calcium

Roy SK, Cespedes A, Li D, Choi TY, Budoff MJ

Vascular Health and Risk Management 2011, 7:719-724

Published Date: 2 December 2011

Readers of this article also read:

Prescribing tests must have curriculum support

Lemon TI, Shah RD

Advances in Medical Education and Practice 2013, 4:91-93

Published Date: 7 May 2013

A sandwich-type DNA electrochemical biosensor for hairpin-stem-loop structure based on multistep temperature-controlling method

Hong GL, Liu YH, Chen W, Weng SH, Liu QC, Liu AL, Zheng DX, Lin XH

International Journal of Nanomedicine 2012, 7:4953-4960

Published Date: 14 September 2012

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience

Hikmat N Abdel-Razeq, Asem H Mansour, Yousef M Ismael

Vascular Health and Risk Management 2011, 7:153-158

Published Date: 15 March 2011

Small coronary vessel angioplasty: outcomes and technical considerations

Sudhir Rathore

Vascular Health and Risk Management 2010, 6:915-922

Published Date: 11 October 2010

Gout disease-specific quality of life and the association with gout characteristics

Jan D Hirsch, Robert Terkeltaub, Dinesh Khanna, et al

Patient Related Outcome Measures 2010, 1:1-8

Published Date: 31 March 2010

Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses

Mohammad Hadi Zafarmand, Yvonne T van der Schouw, Diederick E Grobbee, Peter W de Leeuw, Michiel L Bots

Vascular Health and Risk Management 2008, 4:427-436

Published Date: 11 April 2008

Combination therapy in cholesterol reduction: focus on ezetimibe and statins

Liliana Grigore, Giuseppe Danilo Norata, Alberico L Catapano

Vascular Health and Risk Management 2008, 4:267-278

Published Date: 11 April 2008

Immediate and six months clinical and angiographic results of intracoronary paclitaxel-coated stent implantation – the Meo:DrugStar-1 study

Cihangir Uyan, Huseyin Arinc, Huseyin Gunduz, Ramazan Akdemir

Vascular Health and Risk Management 2008, 4:173-176

Published Date: 8 February 2008